About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Florida | 678 Studies

Clinical Trials Prostate CancerFlorida

Prostate Cancer Clinical Trials in Florida

Find 678 clinical trials for prostate cancer near Florida. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Florida

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 678 trials

CompletedA Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)The purpose of this study was to evaluate the efficacy of enzalutamide plus androgen deprivation therapy (ADT) as measured by radiographic progression-free survival (rPFS) based…NCT02677896·Homewood, Alabama and 202 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingContinued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate LesionsThis extended clinical investigation is a multicenter, prospective, single arm study intended to provide continued access of the Exablate Model 2100 device (Exablate Prostate) to…NCT03998657·Stanford, California and 4 others

Active not recruitingSafety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or…NCT02319837·Birmingham, Alabama and 254 others

RecruitingA Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate CancerThe main purpose of the study is to assess the safety and tolerability of AZD2284, AZD2287, and AZD2275.NCT06879041·Palo Alto, California and 15 others

RecruitingA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)The purpose of this study is to evaluate the overall survival (length of time from the start of study to date of death from any cause) for pasritamig (JNJ-78278343) in Part 1 in…NCT07164443·La Jolla, California and 173 others

UnknownProstate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Androgens can cause the growth of prostate cancer cells.NCT00567580·Birmingham, Alabama and 459 others

RecruitingPrecise Oncology Interventions in Nutrition and Training (OnPoint)The purpose of this study is to see if survivors of breast, prostate, colorectal or lymphoma cancer who receive a personal referral to a targeted nutrition and exercise program…NCT06534918·Miami, Florida

TerminatedA Study of ASP1951 in Subjects With Advanced Solid TumorsThe primary purpose of this study is to evaluate the tolerability and safety profile of ASP1951 when administered as a single agent and in combination with pembrolizumab in…NCT03799003·Tucson, Arizona and 31 others

Active not recruitingAn International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care (SOC), versus Standard of Care alone, in adult male…NCT04720157·Scottsdale, Arizona and 166 others

CompletedCabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate CancerPrimary Objective: * To demonstrate the superiority of cabazitaxel plus prednisone at 25 mg/m\^2 (Arm A) or 20 mg/m\^2 (Arm B) versus docetaxel plus prednisone (Arm C) in term of…NCT01308567·Muscle Shoals, Alabama and 166 others

RecruitingPSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test ScoresThis study will enroll 60 patients previously enrolled to MCC#18523, "A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African-American and…NCT03495427·Tampa, Florida

CompletedA Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate CancerVaccines made from a gene-modified virus may help the body build an effective immune response to kill tumor cells.NCT00108732·Jacksonville, Florida and 6 others

RecruitingPhase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate CancerThis is an open label, phase I, multi-center study aiming to assess the safety and tolerability in patients with metastatic castration resistant prostate cancer (mCRPC).NCT06801236·La Jolla, California and 12 others

CompletedIdentification of Genes Associated With Cancer in Patients and Siblings Who Have CancerRATIONALE: Identification of genes that may be associated with developing certain types of cancer may someday provide important information about a person's risk of getting cancer.NCT00003329·Rancho Mirage, California and 31 others

Temporarily not availableExpanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)The purpose of this program is to provide access to \[Lu-177\]-PNT2002 to patients who have been diagnosed with prostate-specific membrane antigen (PMSA)-positive…NCT06033001·Newport Beach, California and 6 others

TerminatedNeoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSAThe aim of this study is to test whether adding chemotherapy/cabazitaxel and hormonal/androgen deprivation therapy before surgical removal of your prostate would improve the…NCT01531205·Tampa, Florida

TerminatedKZR-261 in Subjects With Advanced Solid MalignanciesA first-in-human, open-label, multicenter, Phase 1 study of KZR-261 designed to assess the safety and tolerability, preliminary anti-tumor activity, and pharmacokinetics (PK) of…NCT05047536·Los Angeles, California and 11 others

CompletedBrachytherapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy through seeds implanted into the prostate may kill more tumor cells.NCT00003312·Birmingham, Alabama and 257 others

CompletedHormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerRATIONALE: Androgens can stimulate the growth of prostate cancer cells.NCT00030654·Phoenix, Arizona and 77 others

TerminatedEPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPCThis is a Phase 1/2 study of EPI-7386 orally administered in combination with enzalutamide in subjects with mCRPC.NCT05075577·Tucson, Arizona and 23 others

PreviousPage 2 of 34Next

Other Conditions in Florida

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma